pravastatin has been researched along with eicosapentaenoic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Iwamoto, T; Kawano, H; Mizuguchi, K; Mochizuki, H; Yamashita, M; Yano, T | 1 |
| Ito, T; Kushihata, S; Masaki, T; Nishida, Y; Oda, H; Taniguchi, Y; Yamakido, M; Yorioka, N | 1 |
| Origasa, H; Yokoyama, M | 1 |
| Kakinuma, C; Naba, H; Ogihara, T; Ohnishi, S | 1 |
| Iketani, T; Takazawa, K; Yamashina, A | 1 |
| Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Miyake, S; Morino, Y; Muramatsu, T; Nozato, T; Nozue, T; Onishi, Y; Sato, A; Takeyama, Y; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T | 1 |
3 trial(s) available for pravastatin and eicosapentaenoic acid
| Article | Year |
|---|---|
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Chemotherapy, Adjuvant; Coronary Artery Disease; Death, Sudden, Cardiac; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prospective Studies; Simvastatin | 2003 |
Effect of eicosapentaenoic acid on central systolic blood pressure.
Topics: Blood Pressure; Eicosapentaenoic Acid; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pravastatin | 2013 |
Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.
Topics: Aged; alpha-Linolenic Acid; Arachidonic Acid; Cholesterol, LDL; Coronary Artery Disease; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Longitudinal Studies; Male; Middle Aged; Pravastatin; Prospective Studies; Quinolines | 2013 |
4 other study(ies) available for pravastatin and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of ethyl-all-cis-5,8,11,14,17-icosapentaenoate (EPA-E), pravastatin and their combination on serum lipids and intimal thickening of cuff-sheathed carotid artery in rabbits.
Topics: Animals; Anticholesteremic Agents; Carotid Arteries; Cholesterol; Drug Interactions; Eicosapentaenoic Acid; Lipids; Male; Phospholipids; Pravastatin; Rabbits; Triglycerides | 1997 |
Lipid-lowering therapy and coagulation/fibrinolysis parameters in patients on peritoneal dialysis.
Topics: Adult; Aged; Anticholesteremic Agents; Blood Coagulation Factors; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Fibrinolysis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Platelet Aggregation Inhibitors; Pravastatin; Statistics, Nonparametric; Treatment Outcome | 2000 |
Improving effect of ethyl eicosapentanoate on statin-induced rhabdomyolysis in Eisai hyperbilirubinemic rats.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbilirubinemia; Muscle, Skeletal; Platelet Aggregation Inhibitors; Pravastatin; Rats; Rhabdomyolysis; Severity of Illness Index; Treatment Outcome | 2006 |